Alzheimer’s disease psychosis
Maplight Therapeutics Inc. is focused on hallucinations and delusions associated with Alzheimer’s disease psychosis, with clinical research centered on symptoms that affect cognition, perception, and behavioral stability in this neuropsychiatric condition.
- Hallucinations
- Delusions
- Neuropsychiatric symptoms
The sponsor’s current research activity is directed toward treatment options for symptom relief in Alzheimer’s disease-related psychosis across multiple collaborating sites.
